メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
九州大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
プロジェクト
研究成果
データセット
活動
プレス/メディア
受賞
専門知識、名前、または所属機関で検索
先端分子・細胞治療科
病院
九州大学病院
概要
フィンガープリント
ネットワーク
プロファイル
(2)
研究成果
(61)
フィンガープリント
先端分子・細胞治療科が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Patient
100%
Therapeutic Procedure
43%
Cells
42%
Combination Therapy
27%
Mogamulizumab
22%
B Cell
21%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
Neoplasm
18%
Cyclophosphamide
18%
Adult
18%
Engraftment
17%
Peptide
16%
T Cell
16%
Chemotherapy
16%
Diseases
16%
Protein
16%
Immunoglobulin
14%
Transplantation
14%
Lymphoma
14%
Adverse Event
13%
Hematopoiesis
13%
Inpatient
12%
Malignant Neoplasm
12%
Gene
11%
Acute Myeloid Leukemia
11%
Graft Versus Host Reaction
11%
Liver
10%
Prednisolone
10%
Spontaneous Remission
10%
Overall Survival
9%
Cord Blood
9%
Hematopoietic Stem Cell
9%
Clinical Trial
9%
Donor
9%
Tumor Antigen
9%
Platelet
8%
Diagnosis
8%
Fever
8%
Prognosis
8%
Stem Cell
8%
Regulatory T Cell
8%
Lesion
8%
Blood
8%
Analysis
8%
Hepatocellular Carcinoma
7%
Bone Marrow
7%
Cytotoxic T-Cell
7%
Embolization
7%
Fascioliasis
7%
B-Cell Chronic Lymphocytic Leukemia
7%
Apoplexy
7%
Ascites
7%
Splenomegaly
7%
Primary Effusion Lymphoma
7%
Oxaliplatin
7%
Scoring System
7%
T Lymphocyte
7%
T Cell Receptor
7%
Bloodstream Infection
7%
Ring Finger
7%
Transcription Factor GATA 1
7%
Regenerative Medicine
7%
Cord Blood Stem Cell Transplantation
7%
Ribavirin
7%
Pneumonia
7%
Solid Malignant Neoplasm
7%
Immunotherapy
7%
B Lymphocyte Receptor
6%
Ecalectin
6%
Lymphocyte
6%
Pediatrics Patient
6%
Small Cell Lung Cancer
6%
Rifampicin
6%
Mixed Connective Tissue Disease
6%
Polymerase Chain Reaction
6%
Toxoplasmosis
6%
In Vitro
6%
Autologous Hematopoietic Stem Cell Transplantation
6%
Enterovirus
5%
Prognostic Factor
5%
Methylprednisolone
5%
Dendritic Cell
5%
Woman
5%
Chemokine Receptor
5%
Beta Chemokine
5%
Mucin 3
5%
Differential Diagnosis
5%
Liver Polycystic Disease
5%
Radiological Finding
5%
Immune Response
5%
Induced Pluripotent Stem Cell
5%
Complementary DNA
5%
Genetic Transduction
5%
DNA Library
5%
Hospital
5%
Hematopoietic Stem Cell Transplantation
5%
Aptitude
5%
Immunology and Microbiology
Mouse
40%
Cells
25%
B Cell
23%
Granulocyte Macrophage Colony-Stimulating Factor
20%
Intravenous Immunoglobulin
17%
Cyclophosphamide
17%
CX3CL1
15%
Transplantation
15%
Cytomegalovirus Infection
14%
Engraftment
13%
Allogeneic Hematopoietic Stem Cell Transplantation
13%
Growth
12%
Human Cell
10%
CD47
9%
Sendai Virus
9%
Host
9%
Myeloid
9%
CX3CR1
8%
Muscle
8%
Time
8%
Immune Response
7%
Immunomodulatory Drug
7%
Lymphoid Organ
7%
Human Leukocyte Antigen
7%
CCL5
7%
Prednisolone
7%
Cytomegalovirus
7%
Ring Finger
7%
Leukotriene B4
7%
Dendritic Cell
7%
Lineages
7%
Incidence
7%
Tumor-Associated Antigen
7%
Vaccine Efficacy
7%
Regulatory T Cell
7%
Gene
6%
B-Cell Receptor
6%
Polymerase Chain Reaction
6%
Toxoplasmosis
6%
Mixed Connective Tissue Disease
6%
Overall Survival
5%
Solid
5%
Lung
5%
Immunity
5%
Acute Graft Versus Host Disease
5%
Natural Killer Cell
5%
Adaptive Immune System
5%
Hematopoietic Stem Cell Transplantation
5%
Hematopoietic Stem Cell
5%
Biochemistry, Genetics and Molecular Biology
Myeloid
27%
Stem Cell
18%
Mouse
15%
CD34
14%
Granulocyte Macrophage Colony-Stimulating Factor
12%
Nested Gene
10%
Protein
9%
Sendai Virus
9%
Electric Potential
8%
T Cell
8%
Protease
7%
RUNX1
7%
Hematopoietic Stem Cell
7%
B Cell
7%
Self Concept
6%
Galectin
6%
Peptide
6%
Genetic Transduction
6%
Hematopoiesis
5%
Mucin
5%
B-Cell Receptor
5%
Induced Pluripotent Stem Cell
5%
Clone
5%
DNA Library
5%
Dendritic Cell
5%
Aptitude
5%